Outcomes of ovarian cancer patients treated with platinum or non-platinum based chemotherapy after PARP inhibitor maintenance. Ralynn Brann,Kevin Michael Kremer,Matthew Carlson,Salvatore LoCoco,Jayanthi Sivasothy Lea,David Scott Miller,Jessica LeeJOURNAL OF CLINICAL ONCOLOGY(2021)引用 3|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要